GUYANA could soon join global trials for antibody treatment of the Novel Coronavirus (COVID-19) disease, said Deputy Chief Medical Officer (DCMO), Dr. Karen Boyle.
The COVID-19 pandemic has reached the shores of over 213 countries and in response to the disease, some of these nations have resorted to clinical trials of various types of treatment, such as the antibody treatment. “We are poised to possibly join some of these trials…the one we are interested in looking at is the transfusion of plasma of convalescent persons – meaning persons, who have been sick, and are winning the battle against the disease,” said Deputy Chief Medical Officer, Dr. Karen Boyle, in a recent recording released by the Ministry of Public Health.
Monoclonal antibody therapy is defined as a form of immunotherapy that uses monoclonal antibodies to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient’s immune system to attack those cells.